Search results

ANSTO providing support to emergency services, closed to non-essential staff.

ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week.  Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.​

The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.

A special inaugural event held by ANSTO at its Australian Synchrotron for more than 30 funding organisations has showcased the first of the $100 million BRIGHT Program’s brand new, state-of-the-art beamlines.

Research to improve knowledge of natural variability in rainfall and recharge by monitoring hydrological processes in key regions and reconstruct water recharge history.

Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.

Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.

Year 11 STEM student and aspiring physicist was given the opportunity of a lifetime to tour ANSTO’s Lucas Heights campus and meet some of Australia’s top researchers.

Minerals Principal Consultant, Dr Karin Soldenhoff, was honoured with the 2024 NSW Women in Mining -Technological Innovation award last week for her work as technical lead on the Australia Strategic Metals (ASM) Dubbo Project, and development of a new solvent extraction technology to separate rare earth and other critical elements.

Nuclear safety expert discusses Fukushima

Environmental researcher joins Science & Technology Australia as Cluster representative for the Chemical Sciences